{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T07:58:53Z","timestamp":1782028733385,"version":"3.54.5"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.leukres.2020.106391","type":"journal-article","created":{"date-parts":[[2020,5,31]],"date-time":"2020-05-31T17:39:35Z","timestamp":1590946775000},"page":"106391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Plasmablastic lymphoma \u2013 single centre experience with infusional EPOCH chemotherapy"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9776-6920","authenticated-orcid":false,"given":"Perumal Kalaiyarasi","family":"Jayachandran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun Kumar","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parathan","family":"Karunakaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangothri","family":"Selvarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivasree","family":"Kesana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manikandan","family":"Dhanushkodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatraman","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tenali Gnana","family":"Sagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2020.106391_bib0005","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1182\/blood.V89.4.1413","article-title":"Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection","volume":"89","author":"Delecluse","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2020.106391_bib0010","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(88)90367-4","article-title":"Updated kiel classification for lymphomas","volume":"331","author":"Stansfeld","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.leukres.2020.106391_bib0015","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00001622-199509000-00003","article-title":"Revised european-american lymphoma classification","volume":"7","author":"Pileri","year":"1995","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.leukres.2020.106391_bib0020","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/hon.660","article-title":"The new World Health Organization classification of lymphomas: the past, the present and the future","volume":"19","author":"Chan","year":"2001","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.leukres.2020.106391_bib0025","first-page":"523","article-title":"The 2008 WHO classification of lymphomas: implications for clinical practice and translational research","volume":"2009","author":"Jaffe","year":"2009","journal-title":"ASH Educ Program Book"},{"key":"10.1016\/j.leukres.2020.106391_bib0030","article-title":"Plasmablastic lymphoma","volume":"96","author":"Han","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.leukres.2020.106391_bib0035","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.leukres.2011.06.023","article-title":"Human immunodeficiency virus (HIV)-negative plasmablastic lymphoma: a single institutional experience and literature review","volume":"35","author":"Liu","year":"2011","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2020.106391_bib0040","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/01.pas.0000126781.87158.e3","article-title":"Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities","volume":"28","author":"Colomo","year":"2004","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.leukres.2020.106391_bib0045","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13045-015-0163-z","article-title":"Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients","volume":"8","author":"Loghavi","year":"2015","journal-title":"J. Hematol. Oncol. J. Hematol. Oncol."},{"key":"10.1016\/j.leukres.2020.106391_bib0050","doi-asserted-by":"crossref","DOI":"10.1186\/s13027-018-0195-4","article-title":"Plasmablastic lymphoma in Malawi","volume":"13","author":"Zuze","year":"2018","journal-title":"Infect Agent Cancer"},{"key":"10.1016\/j.leukres.2020.106391_bib0055","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1182\/blood-2014-10-567479","article-title":"The biology and treatment of plasmablastic lymphoma","volume":"125","author":"Castillo","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2020.106391_bib0060","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.5858\/arpa.2016-0232-RA","article-title":"Plasmablastic lymphoma: a review of clinicopathologic features and differential diagnosis","volume":"140","author":"Harmon","year":"2016","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.leukres.2020.106391_bib0065","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/ajh.21250","article-title":"HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases","volume":"83","author":"Castillo","year":"2008","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.leukres.2020.106391_bib0070","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4103\/sajc.sajc_186_16","article-title":"Plasmablastic lymphoma in immunocompetent and in immunocompromised patients: Experience at a regional cancer centre in India","volume":"6","author":"Rudresha","year":"2017","journal-title":"South Asian J. Cancer"},{"key":"10.1016\/j.leukres.2020.106391_bib0075","series-title":"B - Cell Lymphomas, Version 3.2017","author":"National Comprehensive Cancer Network","year":"2017"},{"key":"10.1016\/j.leukres.2020.106391_bib0080","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1182\/blood-2011-08-373738","article-title":"How I treat HIV-associated lymphoma","volume":"119","author":"Dunleavy","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2020.106391_bib0085","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00277-008-0488-6","article-title":"Prolonged haematological toxicity from the hyper-CVAD regimen: manifestations, frequency, and natural history in a cohort of 125 consecutive patients","volume":"87","author":"Gill","year":"2008","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.leukres.2020.106391_bib0090","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26740","article-title":"Prevalence of multi-drug resistant organisms in stool of paediatric patients with acute leukaemia and correlation with blood culture positivity: a single institution experience","volume":"65","author":"Shankar","year":"2018","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.leukres.2020.106391_bib0095","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2018-99-120366","article-title":"Gut colonization with carbapenem resistant Enterobacteriaceae(CRE) Leads to more chemotherapy inerruptions and higher mortality in patients with acute leukemias receiving remission induction chemotherapy","volume":"132","author":"Kothari","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2020.106391_bib0100","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1182\/blood.V99.8.2685","article-title":"Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy","volume":"99","author":"Wilson","year":"2002","journal-title":"Blood"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212620300965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212620300965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:00:33Z","timestamp":1758934833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212620300965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":20,"alternative-id":["S0145212620300965"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2020.106391","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasmablastic lymphoma \u2013 single centre experience with infusional EPOCH chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2020.106391","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106391"}}